Protox Therapeutics Inc. Reports 2009 Financial Results And Achievements

Published: Mar 31, 2010

VANCOUVER, March 31 /CNW/ - Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today released financial results for the year ended December 31, 2009.

Back to news